nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—peripheral nervous system neoplasm	0.447	1	CbGaD
Reboxetine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0509	0.16	CbGbCtD
Reboxetine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0509	0.16	CbGbCtD
Reboxetine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0353	0.111	CbGbCtD
Reboxetine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0305	0.0961	CbGbCtD
Reboxetine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0284	0.0894	CbGbCtD
Reboxetine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0217	0.0685	CbGbCtD
Reboxetine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0203	0.0639	CbGbCtD
Reboxetine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0199	0.0627	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0136	0.0428	CbGbCtD
Reboxetine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.013	0.041	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0128	0.0403	CbGbCtD
Reboxetine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0119	0.0376	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00814	0.0256	CbGbCtD
Reboxetine—Rash—Melphalan—peripheral nervous system neoplasm	0.000177	0.000752	CcSEcCtD
Reboxetine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000177	0.000752	CcSEcCtD
Reboxetine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000749	CcSEcCtD
Reboxetine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000176	0.000746	CcSEcCtD
Reboxetine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000745	CcSEcCtD
Reboxetine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000744	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000174	0.000741	CcSEcCtD
Reboxetine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000173	0.000737	CcSEcCtD
Reboxetine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000737	CcSEcCtD
Reboxetine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000172	0.00073	CcSEcCtD
Reboxetine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000729	CcSEcCtD
Reboxetine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.000728	CcSEcCtD
Reboxetine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000728	CcSEcCtD
Reboxetine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000724	CcSEcCtD
Reboxetine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000724	CcSEcCtD
Reboxetine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00017	0.000724	CcSEcCtD
Reboxetine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00017	0.000722	CcSEcCtD
Reboxetine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00017	0.000721	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000719	CcSEcCtD
Reboxetine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000719	CcSEcCtD
Reboxetine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000169	0.000718	CcSEcCtD
Reboxetine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000169	0.000718	CcSEcCtD
Reboxetine—Infection—Etoposide—peripheral nervous system neoplasm	0.000167	0.000711	CcSEcCtD
Reboxetine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000167	0.000709	CcSEcCtD
Reboxetine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000167	0.000709	CcSEcCtD
Reboxetine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000707	CcSEcCtD
Reboxetine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000705	CcSEcCtD
Reboxetine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000702	CcSEcCtD
Reboxetine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000165	0.000701	CcSEcCtD
Reboxetine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000164	0.000698	CcSEcCtD
Reboxetine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000164	0.000698	CcSEcCtD
Reboxetine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000164	0.000698	CcSEcCtD
Reboxetine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000697	CcSEcCtD
Reboxetine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000164	0.000696	CcSEcCtD
Reboxetine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000163	0.000695	CcSEcCtD
Reboxetine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000163	0.000691	CcSEcCtD
Reboxetine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000689	CcSEcCtD
Reboxetine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000682	CcSEcCtD
Reboxetine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00016	0.000682	CcSEcCtD
Reboxetine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000679	CcSEcCtD
Reboxetine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000678	CcSEcCtD
Reboxetine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000159	0.000676	CcSEcCtD
Reboxetine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000675	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000674	CcSEcCtD
Reboxetine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000157	0.000668	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000666	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000666	CcSEcCtD
Reboxetine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000659	CcSEcCtD
Reboxetine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000657	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000652	CcSEcCtD
Reboxetine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000651	CcSEcCtD
Reboxetine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000153	0.000651	CcSEcCtD
Reboxetine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000643	CcSEcCtD
Reboxetine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000151	0.000642	CcSEcCtD
Reboxetine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000638	CcSEcCtD
Reboxetine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00015	0.000638	CcSEcCtD
Reboxetine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000636	CcSEcCtD
Reboxetine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00015	0.000636	CcSEcCtD
Reboxetine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000149	0.000634	CcSEcCtD
Reboxetine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000629	CcSEcCtD
Reboxetine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000629	CcSEcCtD
Reboxetine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000148	0.000628	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000627	CcSEcCtD
Reboxetine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000627	CcSEcCtD
Reboxetine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000147	0.000623	CcSEcCtD
Reboxetine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000146	0.000622	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000145	0.000618	CcSEcCtD
Reboxetine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000145	0.000617	CcSEcCtD
Reboxetine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000144	0.000612	CcSEcCtD
Reboxetine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000611	CcSEcCtD
Reboxetine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000611	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00061	CcSEcCtD
Reboxetine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.000606	CcSEcCtD
Reboxetine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000142	0.000604	CcSEcCtD
Reboxetine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000603	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000603	CcSEcCtD
Reboxetine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000593	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00059	CcSEcCtD
Reboxetine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000139	0.00059	CcSEcCtD
Reboxetine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000139	0.000589	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000588	CcSEcCtD
Reboxetine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000138	0.000587	CcSEcCtD
Reboxetine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000138	0.000585	CcSEcCtD
Reboxetine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000137	0.000584	CcSEcCtD
Reboxetine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.000583	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000582	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000582	CcSEcCtD
Reboxetine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000578	CcSEcCtD
Reboxetine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000577	CcSEcCtD
Reboxetine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000575	CcSEcCtD
Reboxetine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000575	CcSEcCtD
Reboxetine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000574	CcSEcCtD
Reboxetine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000134	0.000568	CcSEcCtD
Reboxetine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000566	CcSEcCtD
Reboxetine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000133	0.000565	CcSEcCtD
Reboxetine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000133	0.000565	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000565	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000565	CcSEcCtD
Reboxetine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000132	0.000561	CcSEcCtD
Reboxetine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000132	0.00056	CcSEcCtD
Reboxetine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00056	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000558	CcSEcCtD
Reboxetine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000557	CcSEcCtD
Reboxetine—Rash—Vincristine—peripheral nervous system neoplasm	0.000131	0.000557	CcSEcCtD
Reboxetine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000131	0.000556	CcSEcCtD
Reboxetine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000555	CcSEcCtD
Reboxetine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000553	CcSEcCtD
Reboxetine—Headache—Vincristine—peripheral nervous system neoplasm	0.00013	0.000553	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000549	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000546	CcSEcCtD
Reboxetine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000128	0.000544	CcSEcCtD
Reboxetine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000544	CcSEcCtD
Reboxetine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000534	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000532	CcSEcCtD
Reboxetine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000527	CcSEcCtD
Reboxetine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000124	0.000527	CcSEcCtD
Reboxetine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000526	CcSEcCtD
Reboxetine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000123	0.000524	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000524	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000523	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000518	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000516	CcSEcCtD
Reboxetine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000121	0.000513	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000513	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000512	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000512	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00051	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000509	CcSEcCtD
Reboxetine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000506	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000503	CcSEcCtD
Reboxetine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000496	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000494	CcSEcCtD
Reboxetine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000492	CcSEcCtD
Reboxetine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000492	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000491	CcSEcCtD
Reboxetine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000115	0.000489	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000488	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000487	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000485	CcSEcCtD
Reboxetine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000482	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000481	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000477	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000474	CcSEcCtD
Reboxetine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000111	0.000473	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000472	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000471	CcSEcCtD
Reboxetine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000469	CcSEcCtD
Reboxetine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000109	0.000464	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000457	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000456	CcSEcCtD
Reboxetine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000107	0.000455	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000455	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000454	CcSEcCtD
Reboxetine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000451	CcSEcCtD
Reboxetine—Rash—Etoposide—peripheral nervous system neoplasm	0.000106	0.000451	CcSEcCtD
Reboxetine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000106	0.000451	CcSEcCtD
Reboxetine—Headache—Etoposide—peripheral nervous system neoplasm	0.000105	0.000448	CcSEcCtD
Reboxetine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000446	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000445	CcSEcCtD
Reboxetine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000443	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000441	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000441	CcSEcCtD
Reboxetine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000441	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00044	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000434	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000432	CcSEcCtD
Reboxetine—Nausea—Etoposide—peripheral nervous system neoplasm	0.0001	0.000425	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.000424	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000422	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.00042	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000418	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.000418	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000417	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000415	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.000413	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.00041	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.62e-05	0.000409	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000408	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000408	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000407	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000404	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000402	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.0004	CcSEcCtD
Reboxetine—Infection—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.000398	CcSEcCtD
Reboxetine—Shock—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000394	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000393	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000392	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000391	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000389	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.12e-05	0.000388	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000387	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000386	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000384	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9e-05	0.000382	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000382	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.9e-05	0.000378	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.000375	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000374	CcSEcCtD
Reboxetine—Infection—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000369	CcSEcCtD
Reboxetine—Shock—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000365	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000364	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000363	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000362	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.00036	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.00036	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.44e-05	0.000359	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000357	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000356	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000354	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000353	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000349	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.000347	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000346	CcSEcCtD
Reboxetine—Constipation—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000343	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000336	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000333	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000331	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.77e-05	0.00033	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.00033	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000328	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000327	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000322	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.00032	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000319	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000317	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000317	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000317	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.19e-05	0.000306	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000303	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000295	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000295	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000293	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000293	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.000288	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000274	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000273	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000266	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.000265	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000255	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000254	CcSEcCtD
Reboxetine—Rash—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000253	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000253	CcSEcCtD
Reboxetine—Headache—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000251	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000245	CcSEcCtD
Reboxetine—Nausea—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.000238	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000236	CcSEcCtD
Reboxetine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000234	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000234	CcSEcCtD
Reboxetine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000232	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.00022	CcSEcCtD
